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Abstract 26	
Feline odontoclastic resorptive lesion (FORL) and feline chronic gingivostomatitis 27	
(FCGS) are two of the most common diseases of the feline oral cavity. While evidence is 28	
emerging that FCGS is caused by gingival inflammation initiated and perpetuated by the oral 29	
microbiota, little is known in this regard for FORL. Feline calicivirus (FCV) has been 30	
associated with the presence of FCGS and is thought to play a role in the initiation of this 31	
disease. In this study, the incidence of FCV was investigated in cats with FORL and FCGS, 32	
and compared to unaffected controls. FCV was detected by viral culture. The incidence of 33	
FCV was as follows: 6 (24.0%) of 24 control cats, 9 (22.5%) of 40 cats with FORL and 15 34	
(60.0%) of 25 cats with FCGS were positive for FCV. There was a significant difference in 35	
FCV incidence between all the groups (p=0.003) but none between the control group and the 36	
FORL group. However, significant differences were observed in the incidence of FCV 37	
between control and FCGS (p=0.010) and between FORL and FCGS (p=0.006). It is 38	
concluded that although FCV may be associated with FCGS, it appears unlikely to play a role 39	
in FORL. 40	
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Feline odontoclastic resorptive lesion (FORL) and feline chronic gingivostomatitis (FCGS) 51	
are two of the most common oro-dental diseases of cats. FORL affects more than 60% of cats 52	
over the age of 6 years of age and its incidence increases with age (Lyon, 1992; Reiter and 53	
Mendoza, 2002; Mestrinho et al., 2013). It is a progressive disease characterised by tooth 54	
resorption due to the destructive activity of odontoclasts. FORL manifests as erosion of the 55	
surface of the tooth at the gingival border, with loss of cementum and dentin that leads to 56	
eventual penetration of the pulp cavity. Enamel resorption can also occur, leading to tooth 57	
fracture. Resorbed cementum and dentin is replaced with bone-like tissue. FORL has been 58	
clinically and radiographically classified into five stages (Reiter and Mendoza, 2002), 59	
varying from stage 1 (mild dental hard tissue loss, with lesions extending into the cementum 60	
only) to stage 5 (no crown with only root remnants remaining). FORL causes pain, gingival 61	
inflammation, destruction of periodontal attachment and tooth loss. Since FORL is such a 62	
progressive disease, the only treatment currently available is tooth extraction.  63	
FCGS causes a severe, painful inflammation of the oral cavity that can affect a variety of 64	
sites (White et al., 1992). In its most severe presentation, a proliferative and ulcerative 65	
inflammation is seen at the tissue lateral to the palatoglossal folds (fauces) and the mucosa 66	
overlying the premolar/molar area extending to the buccal mucosa (Hennet et al., 2011). A 67	
wide range of clinical symptoms are often observed, including weight loss, dysphagia, loss of 68	
grooming behaviour, excess salivation and halitosis (Bonello, 2007).  69	
While recent work has focused on the involvement of the oral microbiota in FCGS 70	
(Dolieslager et al., 2011, 2013), comparatively little is known about the involvement of 71	
microbiota in FORL. We hypothesise that the oral microbiota may have an influence on the 72	
inflammatory immune response in FORL, possibly due to changes in the gingival micro-73	
environment, as is the case for FCGS. In this study we compared the incidence of feline 74	
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calicivirus (FCV) infection in cats with FORL, FCGS and unaffected controls in order to 75	
determine whether FCV could be one of the initiating causes of FORL.   76	
A total of 90 cats were recruited to the study from the Nestlé Purina PetCare facility (St. 77	
Joseph, MO, USA): 40 cats with FORL, 25 cats with FCGS and 25 unaffected control cats 78	
with no signs of oral disease.  All cats were either neutered or spayed. Cats were housed 79	
indoors with natural lighting and exposure to natural light cycles in environmentally 80	
controlled rooms in groups based on gender and compatibility.  Cats were provided 81	
environmental enrichment consisting of multiple perches, access to toys, and direct 82	
interaction with caretakers on a daily basis.  Cats had ad libitum access to water and were fed 83	
to maintain an ideal body condition.  The study was conducted in strict accordance with the 84	
guideline established by the Nestlé Purina PetCare (NPPC) Advisory Committee. Apart from 85	
the oral conditions described above, all cats were otherwise in good health and appearance. 86	
All cats had regular dental evaluations and professional cleanings. Presence or absence of 87	
FORL was determined by the presence of obvious erosion of enamel and dentine at the base 88	
of the tooth with localised gingival inflammation; FCGS was diagnosed when severe gingival 89	
inflammation of the gum and mucosa of the palatoglossal folds were observed without signs 90	
of FORL. The presence of FCV virus in oral samples of all cats was determined by culture. In 91	
brief, supragingival plaque samples were collected with a swab, and dispersed in viral 92	
transport medium. Following collection, 200 µl of the transport medium was applied to a 93	
confluent monolayer of Crandall Rees feline kidney cells and incubated for 1 hour at 94	
37ºC.  The transport medium was removed, replaced with growth medium and cells 95	
incubated at 37ºC for 24 hours (Bidawid et al., 2003). Monolayers were examined daily for 96	
six days using an Olympus CK2 inverted microscope at 40x magnification and those showing 97	
cytopathic effects were stained with a fluorescein-labelled mouse anti-FCV antibody (United 98	
States Biologicals, Salem, USA) and visualised using a Leitz Diaplan fluorescent microscope 99	
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at 250x magnification; stained samples were deemed positive for FCV. All analysed samples 100	
were accompanied by both positive and negative controls. Statistical analysis was performed 101	
with GraphPad Prism 5.02 for Windows (GraphPad Software, San Diego CA, USA, 102	
www.graphpad.com) and consisted of a Fisher’s exact test on a contingency table and 103	
ANOVA.  Statistical significance was set at p<0.05. 104	
Signalment of the cats used in the study is shown in Table 1. Due to the mixture of 105	
breeds within the FCGS group, the Fisher’s exact test indicated a significant difference in the 106	
breeds of cats included in the study groups (p=0.010). However, this was unlikely to have 107	
impacted on the study since the proportion of FCV positive Scottish fold cats was two out of 108	
four tested, compared with 13 out of 21 shorthair cats tested.   109	
All cats were greater than 9 months of age with a mean age of 6.1 years.  The three 110	
cohorts comprised a total of 54 male and 36 female cats.  The control group comprised 14 111	
males and 11 females and the average age of these cats was 4.9 years (range 1.7 to 7.5 years); 112	
the FORL group comprised 28 males and 12 females and the average age of these cats was 113	
7.2 years (range 2.9 to 11.4 years); the FCGS group comprised 12 males and 13 females and 114	
the average age of these cats was 6.4 years (range 0.9 to 14.9 years). ANOVA indicated that 115	
the unaffected control cats were significantly younger than the cats with FORL (p=0.005) but 116	
not the cats with FCGS. There was also no significant difference in the mean age of FORL 117	
and FCGS groups. If FCV carriage was directly influenced by age a greater carriage rate 118	
would be expected in the FORL group, but this was not the case. Despite the apparent 119	
discrepancy in gender distribution, there were no significant differences between the control, 120	
FORL and FCGS groups. 121	
Of the 25 unaffected control cats, 6 (24%) cats were positive for FCV.  Of the 40 FORL 122	
cats only 9 (22.5%) were positive for FCV while in the FCGS group 15 (60%) cats were 123	
positive for FCV. Fisher’s exact test indicated a significant difference in FCV incidence 124	
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between all the groups (p=0.003).  There was no significant difference between the control 125	
group and the FORL group with regard to the incidence of FCV.  However, when the control 126	
group was compared with the FCGS group, a significant difference in the incidence of FCV 127	
was observed (p=0.010) and when FORL was compared with FCGS a significant difference 128	
was also observed (p=0.006). However, in case a potential gender imbalance could have 129	
influenced the result, the analysis was repeated on the male cats and female cats separately. 130	
Fisher’s exact test indicated statistically significant differences in their FCV status between 131	
the three groups (p<0.05) and principally between the FORL and FCGS groups (p<0.05). 132	
Our data confirms earlier studies which show a strong association of FCV with FCGS. 133	
Addie et al. (2003) showed that FCV shedding in a cat with FCGS ceased following an 11-134	
month treatment regime to treat FCGS with thalidomide and lactoferrin. FCV RNA was 135	
detected in 17 (40.5%) of 42 cats with FCGS but in none of 19 healthy controls (Dowers et 136	
al., 2010). Virus testing, using the approach in the current study, identified FCV in 22 (71%) 137	
of 31 cats with FCGS but in only 2 (13.3%) of 15 healthy controls (Dolieslager, 2012). In the 138	
current study, somewhat surprisingly, FORL cats had a lower incidence of FCV (22.5%) than 139	
the unaffected control group (24%). Only one previous study has investigated a link between 140	
viral infection and FORL (Hofmann-Lehmann et al., 1998); it was observed that FORL 141	
lesions were more frequent in cats positive for feline immunodeficiency virus than normal 142	
controls. The causes of FORL appear to involve gingival inflammation and are likely to be 143	
multifactorial, as is the case for FCGS, and bacterial and/or viral infections (such as FCV) 144	
may trigger this inflammatory process that eventually leads to FORL. In support of this 145	
hypothesis, investigation of cytokine expression in FORL demonstrated elevated levels of the 146	
cytokines IL-1ß and IL-6 in the ground teeth of cats with FORL compared to normal teeth, 147	
suggesting that they may play a role in mediation of osteoclast activity in FORL (De Laurier 148	
et al., 2002). The same study also suggested that osteoprotegerin may have an inhibitory 149	
	 7	
effect on tooth resorption. However, our current study suggests that FCV is unlikely to have a 150	
causative effect in FORL. Like for FCGS, the mechanisms leading to FORL are 151	
multifactorial and studies are currently ongoing to identify the bacteria associated with FORL 152	
and whether they are able to initiate the disease process via a gingival inflammatory response.  153	
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Table 1 Signalment of cats used in the study 223	
 224	
 Control (n=25) FORL (n=40) FCGS (n=25) 
Sex 
(%) 
14M, 11F 
(56%M, 44%F) 
28M, 12F 
(70%M, 30%F) 
12M, 13F 
(48%M, 56%F) 
Mean age (range) in 
years 
4.9 (1.7–7.5)* 7.2 (2.9–11.4)† 6.4 (0.9–14.9) 
Breed 
 
DSH (25) DSH (40) DSH (21)* 
SF (4) 
 225	
All animals were either neutered (male) or spayed (female) with the exception of one female 226	
cat in the FCGS group.  227	
M, male; F, female; DSH, domestic shorthair; SF, Scottish fold. 228	
*Significantly different from the FORL group.		229	
† Significantly different from the control group. 230	
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Figure 1 Incidence of FCV in cats with FORL, FCGS and unaffected controls  243	
 244	
 245	
The bars show the combined numbers of cats in each group. Shaded bars represent the 246	
number of cats within each group that were positive for FCV; the unshaded bars represent the 247	
number of cats within each group that were negative for FCV. Statistically significant 248	
differences in the presence of FCV in cats is indicated by the bars spanning the respective 249	
groups.  250	
 251	
 252	
